The weekly litigation news digest is live. Subscribe now

IP Verse

Spruce Biosciences competitive analysis

Loading summary...

Latest patents of Spruce Biosciences opposed by its competitors

Explore Spruce Biosciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 11, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3784233
Jun 5, 2024Methods For Treating Testicular And Ovarian Adrenal Rest Tumors1

Latest PTAB cases involving Spruce Biosciences

Discover the latest PTAB cases involving Spruce Biosciences, highlighting their recent legal challenges and patent disputes.

Last updated on: Dec 14, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Spruce Biosciences

PGR2025-00032Feb 10, 2025NEUROCRINE BIOSCIENCESSPRUCE BIOSCIENCESInstitution Denied
PGR2022-00025Feb 18, 2022NEUROCRINE BIOSCIENCESSPRUCE BIOSCIENCESFinal Written Decision
PGR2021-00088May 28, 2021NEUROCRINE BIOSCIENCESSPRUCE BIOSCIENCESFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Spruce Biosciences with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 11, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SPRUCE BIOSCIENCES - 1 - 3
NEUROCRINE BIOSCIENCES113 -